Surge in Cellular and Gene Therapies Challenges FDA

被引:0
|
作者
Wechsler, Jill [1 ]
机构
[1] BioPharm Int, Washington, DC 20005 USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:8 / 9
页数:2
相关论文
共 50 条
  • [31] The innovative evolution of cancer gene and cellular therapies
    Lam, P.
    Khan, G.
    Stripecke, R.
    Hui, K. M.
    Kasahara, N.
    Peng, K-W
    Guinn, B-A
    CANCER GENE THERAPY, 2013, 20 (03) : 141 - 149
  • [32] Emerging cellular and gene therapies for congenital anemias
    Ludwig, Leif S.
    Khajuria, Rajiv K.
    Sankaran, Vijay G.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2016, 172 (04) : 332 - 348
  • [33] Commercialization poses challenges for cell and gene therapies
    Mirasol, Feliza
    Pharmaceutical Technology, 2020, 2020 (03)
  • [34] Gene Therapies for Cancer: Strategies, Challenges and Successes
    Das, Swadesh K.
    Menezes, Mitchell E.
    Bhatia, Shilpa
    Wang, Xiang-Yang
    Emdad, Luni
    Sarkar, Devanand
    Fisher, Paul B.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2015, 230 (02) : 259 - 271
  • [35] Challenges and solutions to the sustainability of gene and cell therapies
    Scotti, Celeste
    Aiuti, Alessandro
    Naldini, Luigi
    NATURE REVIEWS GENETICS, 2025,
  • [36] Cell and Gene Therapies Face Manufacturing Challenges
    Challener, Cynthia A.
    BIOPHARM INTERNATIONAL, 2017, 30 (01) : 20 - +
  • [37] Lentiviral vector gene therapies come of age with two FDA approvals
    Katie Kingwell
    Nature Reviews Drug Discovery, 2022, 21 : 790 - 791
  • [38] Early experience with the FDA's regulatory review of novel gene therapies
    Puthumana, Jeremy
    Egilman, Alexander C.
    Ramachandran, Reshma
    Naushad, Nida
    Shah, Nilay
    Ross, Joseph
    BMJ EVIDENCE-BASED MEDICINE, 2022, 27 (04) : 195 - 198
  • [39] Comparison of Clinical Evidence Submitted to the FDA and EMA for Cell and Gene Therapies
    Elsallab, Magdi
    Gillner, Sandra
    Bourgeois, Florence T.
    JAMA INTERNAL MEDICINE, 2025,
  • [40] Lentiviral vector gene therapies come of age with two FDA approvals
    Kingwell, Katie
    NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (11) : 790 - 791